Rezultati pretraživanja
  1. 15. lis 2019.

    - published an Oped by ' CEO, Dr. Manos Perros, in which he proposes better policies and incentives to revitalize R&D for new drugs. Read the full article here:

  2. 's on the need to combat superbugs. My helps jumpstart our antibiotics pipeline →

  3. 1. lis 2019.

    On the Hill at Congressional offices, meeting with senators and representatives to gain support for and initiatives

  4. 4. velj

    DYK – Bacterial infections are one of the most common complications in patients. No one should have to forego treatment because of . Patients rely on effective . We need action now.

  5. 3. velj

    The antimicrobial market is broken. Legislative changes like the are needed to support the small developers that we depend on for antimicrobial innovation.

  6. 29. sij

    Immediate action is needed to help the companies working to fight . Learn how legislation like the can help stabilize the antimicrobial market and spur the development of life-saving treatments:

  7. 23. sij

    is evolving faster than new development. It is critical that policy makers fix the broken market. Learn more about the rising threat of and how legislation like the that has potential to help

  8. 22. sij

    2020 Priorities for : • Pass the • Support hospital programs. • Tell to better control . • Continue to support combating by funding key agencies.

  9. 17. sij

    Without new action, the threat of will only grow. shares 5 priorities to combat AMR in 2020, including the use of economic incentives and passing the to catalyze the development of new life-saving :

  10. 16. sij

    New policies such as the and novel financial incentives are critical to creating a robust pipeline to fight infections and protect American lives.

    Prikaži ovu nit
  11. 9. sij

    💊 Question: How many new are under development? 💊 Answer: Not nearly enough. We are out of time. Act now - tell your legislators to support the

  12. 30. pro 2019.

    “The business model for developing new is fundamentally broken.” -, Centers for Medicare & Medicaid Services Join the fight. Be part of the change in #2020. Act now 👉

  13. 16. pro 2019.

    is real! In a video series called The Forum presented by the , industry experts discuss how policy and practice in the field can positively affect the looming crisis of . Watch it here:

  14. 14. stu 2019.

    Educating the community about Candida Auris with shout out to

  15. 7. stu 2019.

    Live in the United States 🇺🇸 Ask your Congressional Representative to Co-Sponsor the

  16. . shares current efforts aimed at fixing the broken market including the and calls for additional incentives to help spur development: via

  17. "DISARM was designed to address what is probably the largest barrier to new antibiotic development—the lack of financial incentives for companies to develop new ." Learn how the can help fight : via

  18. 10. lis 2019.

    have proven to be deadlier than cancer. According to Bloomberg , nearly two-thirds of cancer patients in India are affected by antibiotic-resistant infections facing death within 4 weeks.

  19. 21. ruj 2019.

    Common bacteria and yeasts are becoming drug resistant and killing as many as 160,000 Americans each year. That is why passing the is so important. THANK YOU for co-sponsoring S 1712

  20. 18. ruj 2019.

    Act Now: Urge your Senators to Fund the Fight Against Antibiotic Resistance - via

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.